Moonshot AI executives are in settlement talks with shareholder Recurrent.ai over alleged wrongdoing. The dispute, in Hong Kong arbitration since 2024, could raise governance issues for Moonshot's planned Hong Kong listing. Moonshot confidentially filed for IPO in September.
This article explains how workers can use HumanBenchmark.now reaction-time tests to track daily variation and fatigue, while clarifying that scores are not diagnostic or safety clearance tools.
